Report Overview
Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level.
The global Ketorolac Tromethamine market size was estimated at USD 244 million in 2023 and is projected to reach USD 381.78 million by 2032, exhibiting a CAGR of 5.10% during the forecast period.
North America Ketorolac Tromethamine market size was estimated at USD 69.26 million in 2023, at a CAGR of 4.37% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Ketorolac Tromethamine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Ketorolac Tromethamine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Ketorolac Tromethamine market in any manner.
Global Ketorolac Tromethamine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Omeros Corporation
Egalet US Inc.
Allergan
Dr. Reddy�s Laboratories
Teva
Mylan
Apotex
Sandoz
Amphastar Pharmaceuticals
Gland Pharma Limited
Akorn
Sun Pharmaceutical
Sagent Pharmaceuticals
Aurobindo Pharma
Market Segmentation (by Type)
Injection
Ophthalmic
Nasal
Oral tablet
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Ketorolac Tromethamine Market
Overview of the regional outlook of the Ketorolac Tromethamine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Ketorolac Tromethamine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Ketorolac Tromethamine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Ketorolac Tromethamine
1.2 Key Market Segments
1.2.1 Ketorolac Tromethamine Segment by Type
1.2.2 Ketorolac Tromethamine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Ketorolac Tromethamine Market Overview
2.1 Global Market Overview
2.1.1 Global Ketorolac Tromethamine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Ketorolac Tromethamine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Ketorolac Tromethamine Market Competitive Landscape
3.1 Global Ketorolac Tromethamine Sales by Manufacturers (2019-2025)
3.2 Global Ketorolac Tromethamine Revenue Market Share by Manufacturers (2019-2025)
3.3 Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Ketorolac Tromethamine Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Ketorolac Tromethamine Sales Sites, Area Served, Product Type
3.6 Ketorolac Tromethamine Market Competitive Situation and Trends
3.6.1 Ketorolac Tromethamine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Ketorolac Tromethamine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Ketorolac Tromethamine Industry Chain Analysis
4.1 Ketorolac Tromethamine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Ketorolac Tromethamine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Ketorolac Tromethamine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Ketorolac Tromethamine Sales Market Share by Type (2019-2025)
6.3 Global Ketorolac Tromethamine Market Size Market Share by Type (2019-2025)
6.4 Global Ketorolac Tromethamine Price by Type (2019-2025)
7 Ketorolac Tromethamine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Ketorolac Tromethamine Market Sales by Application (2019-2025)
7.3 Global Ketorolac Tromethamine Market Size (M USD) by Application (2019-2025)
7.4 Global Ketorolac Tromethamine Sales Growth Rate by Application (2019-2025)
8 Ketorolac Tromethamine Market Consumption by Region
8.1 Global Ketorolac Tromethamine Sales by Region
8.1.1 Global Ketorolac Tromethamine Sales by Region
8.1.2 Global Ketorolac Tromethamine Sales Market Share by Region
8.2 North America
8.2.1 North America Ketorolac Tromethamine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Ketorolac Tromethamine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Ketorolac Tromethamine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Ketorolac Tromethamine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Ketorolac Tromethamine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Ketorolac Tromethamine Market Production by Region
9.1 Global Production of Ketorolac Tromethamine by Region (2019-2025)
9.2 Global Ketorolac Tromethamine Revenue Market Share by Region (2019-2025)
9.3 Global Ketorolac Tromethamine Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Ketorolac Tromethamine Production
9.4.1 North America Ketorolac Tromethamine Production Growth Rate (2019-2025)
9.4.2 North America Ketorolac Tromethamine Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Ketorolac Tromethamine Production
9.5.1 Europe Ketorolac Tromethamine Production Growth Rate (2019-2025)
9.5.2 Europe Ketorolac Tromethamine Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Ketorolac Tromethamine Production (2019-2025)
9.6.1 Japan Ketorolac Tromethamine Production Growth Rate (2019-2025)
9.6.2 Japan Ketorolac Tromethamine Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Ketorolac Tromethamine Production (2019-2025)
9.7.1 China Ketorolac Tromethamine Production Growth Rate (2019-2025)
9.7.2 China Ketorolac Tromethamine Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Pfizer
10.1.1 Pfizer Ketorolac Tromethamine Basic Information
10.1.2 Pfizer Ketorolac Tromethamine Product Overview
10.1.3 Pfizer Ketorolac Tromethamine Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer Ketorolac Tromethamine SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Omeros Corporation
10.2.1 Omeros Corporation Ketorolac Tromethamine Basic Information
10.2.2 Omeros Corporation Ketorolac Tromethamine Product Overview
10.2.3 Omeros Corporation Ketorolac Tromethamine Product Market Performance
10.2.4 Omeros Corporation Business Overview
10.2.5 Omeros Corporation Ketorolac Tromethamine SWOT Analysis
10.2.6 Omeros Corporation Recent Developments
10.3 Egalet US Inc.
10.3.1 Egalet US Inc. Ketorolac Tromethamine Basic Information
10.3.2 Egalet US Inc. Ketorolac Tromethamine Product Overview
10.3.3 Egalet US Inc. Ketorolac Tromethamine Product Market Performance
10.3.4 Egalet US Inc. Ketorolac Tromethamine SWOT Analysis
10.3.5 Egalet US Inc. Business Overview
10.3.6 Egalet US Inc. Recent Developments
10.4 Allergan
10.4.1 Allergan Ketorolac Tromethamine Basic Information
10.4.2 Allergan Ketorolac Tromethamine Product Overview
10.4.3 Allergan Ketorolac Tromethamine Product Market Performance
10.4.4 Allergan Business Overview
10.4.5 Allergan Recent Developments
10.5 Dr. Reddy�s Laboratories
10.5.1 Dr. Reddy�s Laboratories Ketorolac Tromethamine Basic Information
10.5.2 Dr. Reddy�s Laboratories Ketorolac Tromethamine Product Overview
10.5.3 Dr. Reddy�s Laboratories Ketorolac Tromethamine Product Market Performance
10.5.4 Dr. Reddy�s Laboratories Business Overview
10.5.5 Dr. Reddy�s Laboratories Recent Developments
10.6 Teva
10.6.1 Teva Ketorolac Tromethamine Basic Information
10.6.2 Teva Ketorolac Tromethamine Product Overview
10.6.3 Teva Ketorolac Tromethamine Product Market Performance
10.6.4 Teva Business Overview
10.6.5 Teva Recent Developments
10.7 Mylan
10.7.1 Mylan Ketorolac Tromethamine Basic Information
10.7.2 Mylan Ketorolac Tromethamine Product Overview
10.7.3 Mylan Ketorolac Tromethamine Product Market Performance
10.7.4 Mylan Business Overview
10.7.5 Mylan Recent Developments
10.8 Apotex
10.8.1 Apotex Ketorolac Tromethamine Basic Information
10.8.2 Apotex Ketorolac Tromethamine Product Overview
10.8.3 Apotex Ketorolac Tromethamine Product Market Performance
10.8.4 Apotex Business Overview
10.8.5 Apotex Recent Developments
10.9 Sandoz
10.9.1 Sandoz Ketorolac Tromethamine Basic Information
10.9.2 Sandoz Ketorolac Tromethamine Product Overview
10.9.3 Sandoz Ketorolac Tromethamine Product Market Performance
10.9.4 Sandoz Business Overview
10.9.5 Sandoz Recent Developments
10.10 Amphastar Pharmaceuticals
10.10.1 Amphastar Pharmaceuticals Ketorolac Tromethamine Basic Information
10.10.2 Amphastar Pharmaceuticals Ketorolac Tromethamine Product Overview
10.10.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Product Market Performance
10.10.4 Amphastar Pharmaceuticals Business Overview
10.10.5 Amphastar Pharmaceuticals Recent Developments
10.11 Gland Pharma Limited
10.11.1 Gland Pharma Limited Ketorolac Tromethamine Basic Information
10.11.2 Gland Pharma Limited Ketorolac Tromethamine Product Overview
10.11.3 Gland Pharma Limited Ketorolac Tromethamine Product Market Performance
10.11.4 Gland Pharma Limited Business Overview
10.11.5 Gland Pharma Limited Recent Developments
10.12 Akorn
10.12.1 Akorn Ketorolac Tromethamine Basic Information
10.12.2 Akorn Ketorolac Tromethamine Product Overview
10.12.3 Akorn Ketorolac Tromethamine Product Market Performance
10.12.4 Akorn Business Overview
10.12.5 Akorn Recent Developments
10.13 Sun Pharmaceutical
10.13.1 Sun Pharmaceutical Ketorolac Tromethamine Basic Information
10.13.2 Sun Pharmaceutical Ketorolac Tromethamine Product Overview
10.13.3 Sun Pharmaceutical Ketorolac Tromethamine Product Market Performance
10.13.4 Sun Pharmaceutical Business Overview
10.13.5 Sun Pharmaceutical Recent Developments
10.14 Sagent Pharmaceuticals
10.14.1 Sagent Pharmaceuticals Ketorolac Tromethamine Basic Information
10.14.2 Sagent Pharmaceuticals Ketorolac Tromethamine Product Overview
10.14.3 Sagent Pharmaceuticals Ketorolac Tromethamine Product Market Performance
10.14.4 Sagent Pharmaceuticals Business Overview
10.14.5 Sagent Pharmaceuticals Recent Developments
10.15 Aurobindo Pharma
10.15.1 Aurobindo Pharma Ketorolac Tromethamine Basic Information
10.15.2 Aurobindo Pharma Ketorolac Tromethamine Product Overview
10.15.3 Aurobindo Pharma Ketorolac Tromethamine Product Market Performance
10.15.4 Aurobindo Pharma Business Overview
10.15.5 Aurobindo Pharma Recent Developments
11 Ketorolac Tromethamine Market Forecast by Region
11.1 Global Ketorolac Tromethamine Market Size Forecast
11.2 Global Ketorolac Tromethamine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Ketorolac Tromethamine Market Size Forecast by Country
11.2.3 Asia Pacific Ketorolac Tromethamine Market Size Forecast by Region
11.2.4 South America Ketorolac Tromethamine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Ketorolac Tromethamine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Ketorolac Tromethamine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Ketorolac Tromethamine by Type (2025-2032)
12.1.2 Global Ketorolac Tromethamine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Ketorolac Tromethamine by Type (2025-2032)
12.2 Global Ketorolac Tromethamine Market Forecast by Application (2025-2032)
12.2.1 Global Ketorolac Tromethamine Sales (K MT) Forecast by Application
12.2.2 Global Ketorolac Tromethamine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Ketorolac Tromethamine Market Size Comparison by Region (M USD)
Table 5. Global Ketorolac Tromethamine Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Ketorolac Tromethamine Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Ketorolac Tromethamine Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Ketorolac Tromethamine Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Tromethamine as of 2022)
Table 10. Global Market Ketorolac Tromethamine Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Ketorolac Tromethamine Sales Sites and Area Served
Table 12. Manufacturers Ketorolac Tromethamine Product Type
Table 13. Global Ketorolac Tromethamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Ketorolac Tromethamine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Ketorolac Tromethamine Market Challenges
Table 22. Global Ketorolac Tromethamine Sales by Type (K MT)
Table 23. Global Ketorolac Tromethamine Market Size by Type (M USD)
Table 24. Global Ketorolac Tromethamine Sales (K MT) by Type (2019-2025)
Table 25. Global Ketorolac Tromethamine Sales Market Share by Type (2019-2025)
Table 26. Global Ketorolac Tromethamine Market Size (M USD) by Type (2019-2025)
Table 27. Global Ketorolac Tromethamine Market Size Share by Type (2019-2025)
Table 28. Global Ketorolac Tromethamine Price (USD/MT) by Type (2019-2025)
Table 29. Global Ketorolac Tromethamine Sales (K MT) by Application
Table 30. Global Ketorolac Tromethamine Market Size by Application
Table 31. Global Ketorolac Tromethamine Sales by Application (2019-2025) & (K MT)
Table 32. Global Ketorolac Tromethamine Sales Market Share by Application (2019-2025)
Table 33. Global Ketorolac Tromethamine Sales by Application (2019-2025) & (M USD)
Table 34. Global Ketorolac Tromethamine Market Share by Application (2019-2025)
Table 35. Global Ketorolac Tromethamine Sales Growth Rate by Application (2019-2025)
Table 36. Global Ketorolac Tromethamine Sales by Region (2019-2025) & (K MT)
Table 37. Global Ketorolac Tromethamine Sales Market Share by Region (2019-2025)
Table 38. North America Ketorolac Tromethamine Sales by Country (2019-2025) & (K MT)
Table 39. Europe Ketorolac Tromethamine Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Ketorolac Tromethamine Sales by Region (2019-2025) & (K MT)
Table 41. South America Ketorolac Tromethamine Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Ketorolac Tromethamine Sales by Region (2019-2025) & (K MT)
Table 43. Global Ketorolac Tromethamine Production (K MT) by Region (2019-2025)
Table 44. Global Ketorolac Tromethamine Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Ketorolac Tromethamine Revenue Market Share by Region (2019-2025)
Table 46. Global Ketorolac Tromethamine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Ketorolac Tromethamine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Ketorolac Tromethamine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Ketorolac Tromethamine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Ketorolac Tromethamine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Pfizer Ketorolac Tromethamine Basic Information
Table 52. Pfizer Ketorolac Tromethamine Product Overview
Table 53. Pfizer Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Pfizer Business Overview
Table 55. Pfizer Ketorolac Tromethamine SWOT Analysis
Table 56. Pfizer Recent Developments
Table 57. Omeros Corporation Ketorolac Tromethamine Basic Information
Table 58. Omeros Corporation Ketorolac Tromethamine Product Overview
Table 59. Omeros Corporation Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Omeros Corporation Business Overview
Table 61. Omeros Corporation Ketorolac Tromethamine SWOT Analysis
Table 62. Omeros Corporation Recent Developments
Table 63. Egalet US Inc. Ketorolac Tromethamine Basic Information
Table 64. Egalet US Inc. Ketorolac Tromethamine Product Overview
Table 65. Egalet US Inc. Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Egalet US Inc. Ketorolac Tromethamine SWOT Analysis
Table 67. Egalet US Inc. Business Overview
Table 68. Egalet US Inc. Recent Developments
Table 69. Allergan Ketorolac Tromethamine Basic Information
Table 70. Allergan Ketorolac Tromethamine Product Overview
Table 71. Allergan Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Allergan Business Overview
Table 73. Allergan Recent Developments
Table 74. Dr. Reddy�s Laboratories Ketorolac Tromethamine Basic Information
Table 75. Dr. Reddy�s Laboratories Ketorolac Tromethamine Product Overview
Table 76. Dr. Reddy�s Laboratories Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Dr. Reddy�s Laboratories Business Overview
Table 78. Dr. Reddy�s Laboratories Recent Developments
Table 79. Teva Ketorolac Tromethamine Basic Information
Table 80. Teva Ketorolac Tromethamine Product Overview
Table 81. Teva Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Teva Business Overview
Table 83. Teva Recent Developments
Table 84. Mylan Ketorolac Tromethamine Basic Information
Table 85. Mylan Ketorolac Tromethamine Product Overview
Table 86. Mylan Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Mylan Business Overview
Table 88. Mylan Recent Developments
Table 89. Apotex Ketorolac Tromethamine Basic Information
Table 90. Apotex Ketorolac Tromethamine Product Overview
Table 91. Apotex Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Apotex Business Overview
Table 93. Apotex Recent Developments
Table 94. Sandoz Ketorolac Tromethamine Basic Information
Table 95. Sandoz Ketorolac Tromethamine Product Overview
Table 96. Sandoz Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Sandoz Business Overview
Table 98. Sandoz Recent Developments
Table 99. Amphastar Pharmaceuticals Ketorolac Tromethamine Basic Information
Table 100. Amphastar Pharmaceuticals Ketorolac Tromethamine Product Overview
Table 101. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Amphastar Pharmaceuticals Business Overview
Table 103. Amphastar Pharmaceuticals Recent Developments
Table 104. Gland Pharma Limited Ketorolac Tromethamine Basic Information
Table 105. Gland Pharma Limited Ketorolac Tromethamine Product Overview
Table 106. Gland Pharma Limited Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Gland Pharma Limited Business Overview
Table 108. Gland Pharma Limited Recent Developments
Table 109. Akorn Ketorolac Tromethamine Basic Information
Table 110. Akorn Ketorolac Tromethamine Product Overview
Table 111. Akorn Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Akorn Business Overview
Table 113. Akorn Recent Developments
Table 114. Sun Pharmaceutical Ketorolac Tromethamine Basic Information
Table 115. Sun Pharmaceutical Ketorolac Tromethamine Product Overview
Table 116. Sun Pharmaceutical Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Sun Pharmaceutical Business Overview
Table 118. Sun Pharmaceutical Recent Developments
Table 119. Sagent Pharmaceuticals Ketorolac Tromethamine Basic Information
Table 120. Sagent Pharmaceuticals Ketorolac Tromethamine Product Overview
Table 121. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Sagent Pharmaceuticals Business Overview
Table 123. Sagent Pharmaceuticals Recent Developments
Table 124. Aurobindo Pharma Ketorolac Tromethamine Basic Information
Table 125. Aurobindo Pharma Ketorolac Tromethamine Product Overview
Table 126. Aurobindo Pharma Ketorolac Tromethamine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Aurobindo Pharma Business Overview
Table 128. Aurobindo Pharma Recent Developments
Table 129. Global Ketorolac Tromethamine Sales Forecast by Region (2025-2032) & (K MT)
Table 130. Global Ketorolac Tromethamine Market Size Forecast by Region (2025-2032) & (M USD)
Table 131. North America Ketorolac Tromethamine Sales Forecast by Country (2025-2032) & (K MT)
Table 132. North America Ketorolac Tromethamine Market Size Forecast by Country (2025-2032) & (M USD)
Table 133. Europe Ketorolac Tromethamine Sales Forecast by Country (2025-2032) & (K MT)
Table 134. Europe Ketorolac Tromethamine Market Size Forecast by Country (2025-2032) & (M USD)
Table 135. Asia Pacific Ketorolac Tromethamine Sales Forecast by Region (2025-2032) & (K MT)
Table 136. Asia Pacific Ketorolac Tromethamine Market Size Forecast by Region (2025-2032) & (M USD)
Table 137. South America Ketorolac Tromethamine Sales Forecast by Country (2025-2032) & (K MT)
Table 138. South America Ketorolac Tromethamine Market Size Forecast by Country (2025-2032) & (M USD)
Table 139. Middle East and Africa Ketorolac Tromethamine Consumption Forecast by Country (2025-2032) & (Units)
Table 140. Middle East and Africa Ketorolac Tromethamine Market Size Forecast by Country (2025-2032) & (M USD)
Table 141. Global Ketorolac Tromethamine Sales Forecast by Type (2025-2032) & (K MT)
Table 142. Global Ketorolac Tromethamine Market Size Forecast by Type (2025-2032) & (M USD)
Table 143. Global Ketorolac Tromethamine Price Forecast by Type (2025-2032) & (USD/MT)
Table 144. Global Ketorolac Tromethamine Sales (K MT) Forecast by Application (2025-2032)
Table 145. Global Ketorolac Tromethamine Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Ketorolac Tromethamine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Ketorolac Tromethamine Market Size (M USD), 2019-2032
Figure 5. Global Ketorolac Tromethamine Market Size (M USD) (2019-2032)
Figure 6. Global Ketorolac Tromethamine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Ketorolac Tromethamine Market Size by Country (M USD)
Figure 11. Ketorolac Tromethamine Sales Share by Manufacturers in 2023
Figure 12. Global Ketorolac Tromethamine Revenue Share by Manufacturers in 2023
Figure 13. Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Ketorolac Tromethamine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Ketorolac Tromethamine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Ketorolac Tromethamine Market Share by Type
Figure 18. Sales Market Share of Ketorolac Tromethamine by Type (2019-2025)
Figure 19. Sales Market Share of Ketorolac Tromethamine by Type in 2023
Figure 20. Market Size Share of Ketorolac Tromethamine by Type (2019-2025)
Figure 21. Market Size Market Share of Ketorolac Tromethamine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Ketorolac Tromethamine Market Share by Application
Figure 24. Global Ketorolac Tromethamine Sales Market Share by Application (2019-2025)
Figure 25. Global Ketorolac Tromethamine Sales Market Share by Application in 2023
Figure 26. Global Ketorolac Tromethamine Market Share by Application (2019-2025)
Figure 27. Global Ketorolac Tromethamine Market Share by Application in 2023
Figure 28. Global Ketorolac Tromethamine Sales Growth Rate by Application (2019-2025)
Figure 29. Global Ketorolac Tromethamine Sales Market Share by Region (2019-2025)
Figure 30. North America Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Ketorolac Tromethamine Sales Market Share by Country in 2023
Figure 32. U.S. Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Ketorolac Tromethamine Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Ketorolac Tromethamine Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Ketorolac Tromethamine Sales Market Share by Country in 2023
Figure 37. Germany Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Ketorolac Tromethamine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Ketorolac Tromethamine Sales Market Share by Region in 2023
Figure 44. China Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Ketorolac Tromethamine Sales and Growth Rate (K MT)
Figure 50. South America Ketorolac Tromethamine Sales Market Share by Country in 2023
Figure 51. Brazil Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Ketorolac Tromethamine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Ketorolac Tromethamine Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Ketorolac Tromethamine Production Market Share by Region (2019-2025)
Figure 62. North America Ketorolac Tromethamine Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Ketorolac Tromethamine Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Ketorolac Tromethamine Production (K MT) Growth Rate (2019-2025)
Figure 65. China Ketorolac Tromethamine Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Ketorolac Tromethamine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Ketorolac Tromethamine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Ketorolac Tromethamine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Ketorolac Tromethamine Market Share Forecast by Type (2025-2032)
Figure 70. Global Ketorolac Tromethamine Sales Forecast by Application (2025-2032)
Figure 71. Global Ketorolac Tromethamine Market Share Forecast by Application (2025-2032)
